KNW

Know Labs

--(--)

Market Open: --

--(--)

Post-Market: --

Key Stats

--DAY`S RANGE--

--52 WK RANGE--

Open

Prev.Close

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

Low

52 Week High

52 Week Low

About KNW

Know Labs, Inc.

Blood glucose monitor developer

Industry

Life Science Tools and Services

Established Date

10/08/1998

Listing Date

03/05/2025

Exchange

American Stock Exchange

Full-time Employees

Fiscal Year Ends

09-30

Website

www.knowlabs.co

Security Type

Common stock

Office address

619 Western Avenue, Suite 610, Seattle, Washington 98104

Business

Introduction

Know Labs, Inc., was incorporated in Nevada on October 8, 1998. The company is an emerging leader in non-invasive medical diagnosis. They focus on developing and commercializing their proprietary sensor technologies using radio and microwave dielectric spectroscopy technologies. The first application of their sensor technology is a product for non-invasive monitoring of blood glucose levels. Their device is designed to give users real-time information about their blood sugar levels.

Company Financials

EPS

KNW has released its 2025 Q1 earnings. EPS was reported at -0.04, versus the expected -0.05, beating expectations. The chart below visualizes how KNW has performed over recent quarters, highlighting trends in earnings surprises.